Latest Form 4 insider transactions

D Jonathan Merriman, a Director of PodcastOne, Inc., purchased 11,000 shares of common stock on September 24, 2026 for $2.21 per share.

Michael Fierman, a Director and 10% owner of Angel Oak Mortgage REIT, Inc., purchased 38,726 shares of common stock on September 25, 2026 for $7.50 per share.

Robert Weir, See Remarks of Guardian Pharmacy Services, Inc., reported multiple transactions in common stock on September 27, 2026.

City National Rochdale Strategic Credit Fund, an interval fund focused on debt securities and credit-related investments, has filed an amendment to its registration statement, detailing its investment strategies, risks, and operational updates.

John Ackerman, a Director of Guardian Pharmacy Services, Inc., reported multiple transactions in common stock on September 27, 2026.

Ugur Sahin, Chief Executive Officer and 10% owner of BioNTech SE, sold 61,000 shares of common stock on September 25, 2026.

Thomas J Salentine Jr, a Director and 10% owner of Guardian Pharmacy Services, Inc., reported multiple transactions in common stock on September 27, 2026.

Kimberly S Lubel, a Director of Arcosa, Inc., reported a transaction in 683 shares of common stock on September 25, 2026.

Louis Edward Tamayo, Chief Financial Officer of Lexeo Therapeutics, Inc., received 54,750 shares of common stock on September 24, 2026.

Narinder Pal Bhalla, Chief Medical Officer of Lexeo Therapeutics, Inc., reported multiple transactions in common stock on September 24, 2026.

Jose Manuel Otero, Chief Operating Officer of Lexeo Therapeutics, Inc., reported multiple transactions in common stock on September 24, 2026.

Richard Nolan Townsend, Chief Executive Officer and a Director of Lexeo Therapeutics, Inc., reported multiple transactions in common stock on September 24, 2026.

David Norman Martin, See Remarks of Guardian Pharmacy Services, Inc., reported multiple transactions in common stock on September 27, 2026.

Anthony Puntillo, a Director of Finward Bancorp, purchased 5 shares of common stock on September 25, 2026 for $43.46 per share.

Pharmacy Investors, LLC reported changes in beneficial ownership of Guardian Pharmacy Services, Inc. common stock on September 27, 2026.

Fred Burke, See Remarks and a Director of Guardian Pharmacy Services, Inc., reported multiple transactions in common stock on September 27, 2026.

Benjamin J Bochnowski, President, CEO and a Director of Finward Bancorp, purchased 5 shares of common stock on September 25, 2026 for $43.48 per share.

Jeffrey Tuch, See Remarks of Guardian Pharmacy Services, Inc., reported multiple transactions in common stock on September 27, 2026.

Robert T Lowry, Executive Vice President of Finward Bancorp, purchased 42 shares of common stock on September 25, 2026 for $43.48 per share.

Kendall Forbes, Member of 10% Owner Group of Guardian Pharmacy Services, Inc., reported multiple transactions in common stock on September 27, 2026.

Christopher B Paisley, a Director of Ambarella Inc, sold 250 shares of common stock on September 25, 2026 for $70.76 per share.

William E Bindley, a Director and 10% owner of Guardian Pharmacy Services, Inc., reported multiple transactions in common stock on September 27, 2026.

Steven L Zatz, President of Doximity, Inc., reported multiple transactions in common stock on September 24, 2026.

Ryan T. Sakamoto, EVP, Chief Legal Officer of Ziprecruiter, Inc., sold 2,978 shares of common stock on September 25, 2026 for $3.49 per share.

David K Morris, See Remarks and a Director of Guardian Pharmacy Services, Inc., reported multiple transactions in common stock on September 27, 2026.

John Martin Schaible, Executive Chairman and a Director of AtlasClear Holdings, Inc., purchased 100,000 shares of common stock on September 24, 2026.

David Craig Ridenhour, President and a Director of AtlasClear Holdings, Inc., purchased 100,000 shares of common stock on September 24, 2026.

Sandip I Patel, CFO & General Counsel and a Director of AtlasClear Holdings, Inc., purchased 100,000 shares of common stock on September 24, 2026.

Steven J. Carlson, a Director of AtlasClear Holdings, Inc., purchased 15,000 shares of common stock on September 24, 2026.

Thomas Jon Hammond, a Director of AtlasClear Holdings, Inc., purchased 500,000 shares of common stock on September 24, 2026 for $0.20 per share.